Jeff Bak

Oct 27, 2024 | medcitynews.com | Frank Vinluan |Jeff Bak |Stephanie Baum

Six months after launching with a mega-round of financing, Seaport Therapeutics has raised $225 million more to advance a lead drug candidate that could overcome some limitations of currently available treatments for depression. Seaport’s platform technology, called Glyph, designs oral drugs that leverage the lymphatic system to deliver the medicine in a way that makes more of the active pharmaceutical ingredient available in the body to confer its therapeutic effect.

Oct 25, 2024 | medcitynews.com | Emily Peters |Jeff Bak

Hospitals are a fascinating space to study color. Inside the walls of emergency departments and patient wards are choices influenced by hundreds of years of medical culture. The vector of color often feels unconsciously selected in the evolution of these hospital settings — filled with medical devices, flooring, and furniture designed primarily for durability, risk-reduction, and stain prevention.

Oct 2, 2024 | medcitynews.com | Frank Vinluan |Jeff Bak |Monica Vajani

Eli Lilly’s R&D has yielded innovations such as the metabolic disorder drugs Mounjaro and Zepbound, both discovered in the company’s labs. Lilly is now committing $4.5 billion for in-house innovations in the manufacturing of medicines. The pharmaceutical giant on Tuesday announced plans for a new facility, Lilly Medicine Foundry, which it says will research new ways of producing medicines. The site will also enable the company to scale up the manufacturing of experimental drugs for clinical trials.

Oct 1, 2024 | medcitynews.com | Katie Adams |Jeff Bak |Stephanie Baum

Medical coding is an unavoidable part of healthcare delivery. Coding is essential for accurate documentation, billing and reimbursement in healthcare — yet many providers still rely on manual coding practices that eat up staff members’ time. On Tuesday, Nym raised $47 million to help solve this problem. The New York City-based startup announced a funding round led by PSG, with participation from Google Ventures, Addition, Samsung Next and Dynamic Loop Capital.

Oct 1, 2024 | medcitynews.com | Marissa Plescia |Monica Vajani |Jeff Bak

Lyra Health, a mental health company, announced Monday that it is expanding its substance use disorder services to support those struggling with cannabis, stimulants, opioids and nicotine. Burlingame, California-based Lyra Health sells to employers and health plans and offers self-guided programs, mental health coaching, therapy and medication management. Patients can receive their care in person, via video or through text messaging.